STOCK TITAN

Tango Therapeutics director proposes $183K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

John Ketchum, a director of Tango Therapeutics, Inc. (TNGX), filed notice of a proposed sale of 7,590 common shares, with an aggregate market value of $183,450.30 and an approximate sale date of November 17, 2026. The shares were acquired through restricted stock unit vesting from August 19, 2024, through August 17, 2026.

Shares proposed for sale 7,590 shares Common shares listed for the proposed sale
Aggregate market value $183,450.30 Value listed for the proposed sale
Approximate sale date November 17, 2026 Approximate date listed for the proposed sale
Shares outstanding 169,455,160 shares Issuer shares outstanding listed in the notice
Plan adoption or instruction date August 18, 2026 Date listed if relying on Rule 10b5-1
Restricted Stock Units financial
"shares acquired upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TNGX shares is John Ketchum proposing to sell?

John Ketchum, a Tango Therapeutics director, reported a proposed sale of 7,590 common shares, with an aggregate market value of $183,450.30 and an approximate sale date of November 17, 2026.

What Rule 10b5-1 date is listed for John Ketchum’s proposed TNGX sale?

The notice lists August 18, 2026, as the date of plan adoption or giving of instruction if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading